Literature DB >> 10701095

Miscellaneous treatments: thalidomide, potassium iodide, levamisole, clofazimine, colchicine, and D-penicillamine.

M R Sanchez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10701095     DOI： 10.1016/s0738-081x(99)00103-0

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  3 in total

Review 1.  Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control.

Authors:  G Tintinger; H C Steel; R Anderson
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

2.  Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species.

Authors:  Takahiro Yano; Sacha Kassovska-Bratinova; J Shin Teh; Jeffrey Winkler; Kevin Sullivan; Andre Isaacs; Norman M Schechter; Harvey Rubin
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

3.  Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation.

Authors:  Yu Lu; Meiqin Zheng; Bin Wang; Lei Fu; Weijie Zhao; Peng Li; Jian Xu; Hui Zhu; Haixia Jin; Dali Yin; Haihong Huang; Anna M Upton; Zhenkun Ma
Journal:  Antimicrob Agents Chemother       Date:  2011-08-15       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.